Acute Symptomatic Seizures
The Neurologist 18:109-119, Beleza,P., 2012
Epilepsy in Children
Lancet 367:499-524, Guerrini,R., 2006
Status Epilepticus: A Review of Different Syndromes, Their Current Evaluation, and Treatment
The Neurologist 9:61-76, Gaitanis,J.N. &Drislane,F.W., 2003
Chronic Diarrhea Associated with Vagal Nerve Stimulation
Neurol 58:330, Sanossian,N. &Haut,S., 2002
Patients with Refractory Seizures
NEJM 340:1565-1570, Devinsky,O, 1999
Seizures and Epilepsy in the Elderly
Arch Int Med 157:605-617, Thomas,R.J., 1997
Epilepsy in Childhood
BMJ 315:924-930, Neville,B.G.R., 1997
Clinicopath Conf
Focal Cortical Dysplasia, Case 7-1996, NEJM 334:586-592996., , 1996
Long-Term Therapeutic Management of Epilepsy
Ann Int Med 120:411-422, French,J., 1994
The Role of Epilepsy Centers in Delivering Care to Patients with Intractable Epilepsy
Neurol 44:1347-1352, Lesser,R.P., 1994
Seizure Disorder
Ciba Clin Symposia 46:4-34, Devinsky,O., 1994
Epilepsy
JNNP 57:264-277, Chadwick,D., 1994
Juvenile Myoclonic Epilepsy
Arch Neurol 50:594-598, Grunewald,R.A.&Panayiotopoulos,C.P., 1993
Presenting the Diagnosis of Pseudoseizure
Neurol 40:756-759, Shen,W.,et al, 1990
Diagnosis of Epilepsy
Lancet 336:291-295, Chadwick,D., 1990
New Uses and Old for Carbamazepine
Patient Care 24:48-81, Browne,T.R.,et al, 1990
The Evaluation and Treatment of Seizures
NEJM 323:1468-1474, Scheuer,M.L.&Pedley,T.A., 1990
Pseudostatus Epilepticus
Editorial, Lancet 2:4851989., , 1989
Pseudostatus Epilepticus
Quart J Med 71:507-519, Howell,S.J.L.,et al, 1989
Calcium Channels & Calcium Channel Antagonists
Ann Neurol 21:317-330, Greenberg,D.A., 1987
Neonatal Seizures
NEJM 388:1692-1700, Ropper.A.H., 2023
Drug Resistant Epilepsy in a 61-Year-Old Man with Abnormal MRI Brain Findings and Management with Vagal Nerve Stimulator
Neurol 100:1111-1116, Mankad,J.P. & Lavingia,J.R., 2023
The SANAD II study of the Effectiveness and Cost-Effectiveness of Levetiracetam, Zonisamide, or Lamotrigine for Newly Diagnosed Focal Epilepsy: An Open-Label, Non-Inferiority, Multicentre, Phase 4, Randomised Controlled Trial
Lancet 397:1363-1374, Marson, A.,et al, 2021
The SANAD II Study of the Effectiveness and Cost-Effectiveness of Valproate Versus Levetiracetam for Newly Diagnosed Generalised and Unclassifiable Epilepsy: An Open-Label, Non-Inferiority, Multicentre, Phase 4, Randomised Controlled Trial
Lancet 397:1375-1386, Marson, A.,et al, 2021
Vagus Nerve Stimulation and Seizure Outcomes in Pediatric Refractory Epilepsy
Neurol 96:1041-1051, Jain, P. & Arya, R., 2021
Initial Management of Seizure in Adults
NEJM 385:251-263, Smith, P.E.M., 2021
Safety and Efficacy of Coma Induction Following First-Line Treatment in Status Epilepticus
Neurol 97:e564-e576, DeStefano, P.,et al, 2021
Clinicopathologic Conference, Seizure from Neurocysticercosis
NEJM 385:1894-1902, Case 34-2021, 2021
Antiseizure Medication Withdrawal in Seizure-Free Patients: Practice Advisory Update Summary
Neurol 97:1072-1081, Gloss, D.,et al, 2021
Epilepsy in Older People
Lancet 395:735-748, Sen, A.,et al, 2020
Deprescribing in Epilepsy
JAMA Neurol 77:673-674, Terman, S.W.,et al, 2020
Choosing Anticonvulsant Medications to Manage Status Epilepticus
NEJM 382:2569-2572, Wu, K., 2020
FDA Approves Fenfluramine for Treatment of Seizures Associated with Dravet Syndrome
FDA June2020, , 2020
Efficacy and Safety of Adjunctive Lacosamide in the Treatment of Primary Generalised Tonic-Clonic Seizures: A Double-Blind, Randomised, Placebo-Controlled Trial
JNNP 91:1067-1075, Vossler, D.G.,et al, 2020
Antiepileptic Drug Treatment Patterns in Women of Childbearing Age with Epilepsy
JAMA Neurol 76:783-790, Kim, H.,et al, 2019
Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus
NEJM 381:2103-2113,2171, Kapur, J.,et al, 2019
Cannabidiol in Patients with Seizures Associated with Lennox-Gastaut Syndrome (GWPCARE4): A Randomised, Double-Blind, Placebo-Controlled Phase 3 Trial
Lancet 391:1085-1096, Thiele, E.A.,et al, 2018
Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome
NEJM 378:1888-1897, Devinsky, O.,et al, 2018
Efficacy and Tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy
Neurol 91:82-90, Kanner, A.M.,et al, 2018
Efficacy and Tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy
Neurol 91:74-81, Kanner, A.M.,et al, 2018
Antiepileptic Drug Treatment After An Unprovoked First Seizure
Neurol 91:e1429-e1439,684, Bao, E.L.,et al, 2018
Tocilizumab Treatment for New Onset Refractory Status Epilepticus
Ann Neurol 84:940-945, Jun, J.,et al, 2018
Switching the Manufacturer of Antiepileptic Drugs is Associated with Higher Risk of Seizures: A Nationwide Study of Prescription Data in Germany
Ann Neurol 84:918-925, Lang, J.D.,et al, 2018
Successful Management of Super-Refractory Status Epilepticus with Thalamic Deep Brain Stimulation
Ann Neurol 81:142-146, Lehtimaki, K.,et al, 2017
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
NEJM 376:2011-2020, Devinsky, O.,et al, 2017
A 62-Year-Old Woman with Bizarre Behavior and Recurrent Episodes of Behavioral Arrest
Neurol 86:e62-e65, Briglia, H.,et al, 2016
Resective Epilepsy Surgery for Drug-Resistant Focal Epilepsy
JAMA 313:285-293, Jobst, B.C. & Cascino, G.D., 2015
Epilepsy: New Advances
Lancet 385:884-898, Moshe, S.L.,et al, 2015
Evidence-Based Guideline: Management of an Unprovoked First Seizure in Adults
Neurol 84:1705-1713, Krumholz, A.,et al, 2015